Hunter Biden Suggests Fathers Withdrawal From 2024 Race Linked to Epstein Class Allegations Technical Analysis Highlights Select Stocks Amid Market Weakness Amazon and GE Vernova Among Stocks Approaching Key Levels as Market Strength Persists Why US 10Year Bond Yields Serve as a Critical Market Barometer for Global Investors Chinas DeepSeek AI Claims Breakthrough HighPerformance Models Trained Without Advanced Chips Prediction Market Suggests IonQ Micron and Anduril as Potential Next US Government Stake Targets M Q1 2026 Earnings EPS Beats Estimates by 673 Stock Rises DXC Q1 2026 Earnings EPS Surpasses Estimates as Cost Actions Drive Profitability Citi Q1 2026 Earnings EPS Surpasses Estimates by 133 Amid Improved Operational Efficiency KMI Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds Origin Agritech Limited SEED Q4 2011 Earnings EPS Surges Past Expectations Despite Missing Revenue Details V Q1 2026 Earnings EPS Surges Past Estimates Revenue Data Pending LENZ Therapeutics LENZ Edges Lower as Stock Tests Support at 730 PRH Preferred Stock Holds Steady Near 2308 as YieldSeeking Investors Eye Support VirTra Inc VTSI Edges Higher as Stock Finds Footing Above Key Support Spectrum Brands Surges 373 as Stock Approaches Resistance at 8227 Glaukos GKOS Plunges 135 as Key Support Tested Whats Next for the MedTech Stock KYECs New Singapore Facility to Create Over 300 Jobs Expands Chip Testing Capacity Meridian Corporation MRBK Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly New Concept Energy GBR Gains Ground Testing Key Resistance at 085 Harte Harte Hanks Inc Q2 2025 Earnings Narrowed Loss Amid Strategic Transformation RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction INDI Q1 2026 Earnings EPS Misses Estimates Slightly Stock Rallies 54 SSB Q1 2026 Earnings EPS Beats Estimates Amid Stable Banking Operations BHB Q1 2026 Earnings EPS Misses Estimates Shares Dip Slightly Sequans Communications Q1 2026 Earnings Significant Earnings Miss Amid Strategic Challenges SLDB Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline